HOME >> MEDICINE >> NEWS
Stanford patient is first to test new treatment for peripheral arterial disease

STANFORD, Calif. - For several years, crippling leg pain has prevented Joan Erickson from walking more than a block. If she paused to rest, she could walk a little more, but not enough to continue playing golf, her favorite pastime.

An ultrasound and CT scan early this year showed that an artery in Erickson's thigh was almost completely blocked, confirming that her troubles were caused by peripheral arterial disease, or PAD - a condition in which arteries to the arms, legs or internal organs are hardened and narrowed or obstructed.

This week at Stanford University Medical Center, Erickson became the first patient in the United States to receive a new treatment for PAD as part of a clinical trial. On March 21, Stanford researchers implanted a drug-coated, flexible, metal-mesh tube called a drug-eluting stent into the superficial femoral artery in Erickson's thigh. Researchers hope the drug coating will make it more likely to prevent the blockage from recurring, as compared with uncoated stents, which fail to do so in about one-quarter of the cases.

"We already know the benefits of drug-coated stents for the treatment of coronary artery disease," said Michael Dake, MD, a former Stanford faculty member who recently became chair of radiology at the University of Virginia and is the principal investigator of the multi-center study. "We're hoping to translate that success to the peripheral circulation, especially in the legs where blockages can be disabling."

Peripheral arterial disease afflicts 8 million to 12 million Americans, many of whom have not been diagnosed, according to the American Heart Association. The most common symptoms are pain in the legs or buttocks while walking or climbing stairs. Risk factors for PAD are the same as for heart disease: smoking, diabetes, high blood pressure and a high cholesterol level. People with PAD are also at high risk for heart attacks and strokes. The disease can be treated with diet,
'"/>


23-Mar-2005


Page: 1 2 3

Related medicine news :

1. Protein that helps skin cancer spread identified by Stanford researchers
2. Computer model being developed at Stanford may help surgeons better predict patient outcomes
3. Brain-scanning technologies need standards, according to Stanford researcher
4. Young blood revives aging muscles, Stanford researchers find
5. Brain synapse formation linked to proteins, Stanford study finds
6. Early HIV screening prolongs life and is affordable, Stanford study shows
7. Vioxx went mostly to patients who didnt need it, Stanford researcher says
8. Stanford study shows hypnosis helps kids undergoing difficult procedure
9. Ethics of neuroimaging research to be focus of NIH/Stanford meeting
10. Early learning leaves lasting changes in brain, Stanford owl study shows
11. Stanford study finds new method improves chemotherapy survival in mice

Post Your Comments:
(Date:6/18/2013)... College, PA (PRWEB) June 18, 2013 ... months, produces increased fluid retention through the tip allowing ... using the Salimetrics Infant Swab (SIS) can ... IL-1beta and Chromogranin A. , The diameter of the ... This allows the new swab to access more saliva ...
(Date:6/17/2013)... New York, NY (PRWEB) June 17, 2013 ... represents the victims of child sexual abuse and their co-counsel, ... child sexual abuse lawsuit the firms filed on ... a Brooklyn Supreme Court Referee on Wednesday awarded $3.5 million ... by his cousin. Following the Referee’s finding in his ...
(Date:6/17/2013)... AZ (PRWEB) June 17, 2013 Vince Del Monte ... Max program they released last year and it will only be ... exclusive 4 day sale Ryan Davids has released an updated Hypertrophy ... can access the Hypertrophy Max review here . , Davids ... some major bonuses during this 4 day sale as an extra ...
(Date:6/17/2013)... distribution of white matter brain abnormalities in some patients ... found in early Alzheimer,s dementia, according to a new ... , "Findings of MTBI bear a striking resemblance ... study,s lead author, Saeed Fakhran, M.D., assistant professor of ... of Pittsburgh School of Medicine. "Additional research may help ...
(Date:6/17/2013)... (PRWEB) June 17, 2013 Daily Gossip ... therefore, publish a thorough review of the Tinnitus ... Daily Gossip presents the natural treatment that ... patients who have tested it. , Based on the ... natural Tinnitus treatment suggested by Thomas Coleman ...
Breaking Medicine News(10 mins):Health News:Salimetrics Redesigns Infant Swab for Faster, Easier Collection 2Health News:Child Sexual Abuse Lawsuit Victim Awarded $3.5 Million by Brooklyn Supreme Court Referee, Plaintiff Represented by Alonso Krangle LLP 2Health News:Child Sexual Abuse Lawsuit Victim Awarded $3.5 Million by Brooklyn Supreme Court Referee, Plaintiff Represented by Alonso Krangle LLP 3Health News:Updated Hypertrophy Max Review Released for Vince Del Monte and Ben Pakulski's Hypertrophy Max Training Program 2Health News:Concussion patients show Alzheimer's-like brain abnormalities 2Health News:Concussion patients show Alzheimer's-like brain abnormalities 3Health News:Thomas Coleman's Tinnitus Miracle Treatment Review Discloses Alternative Natural Cure 2
(Date:6/17/2013)... Franciscan St. Francis Health Cancer Center today (June ... to use a new drug to treat men ... Xofigo ®, a radiopharmaceutical used in patients with late-stage, metastatic ... approved for use by the U.S. Food and Drug Administration. ... may become castration-resistant, which has become resistant to medical or ...
(Date:6/17/2013)... June 17, 2013  Today BioSpace , the leading ... BioCapital Hotbed map campaign spotlighting the life sciences community ... , Delaware and Washington ... ) The BioCapital area continues to ... BioSpace.com average 21 applies each - a strong ...
(Date:6/17/2013)... 2013 Actavis, Inc. (NYSE: ACT ) ... the decision of the U.S. Court of Appeals for the ... Actavis, motion to dismiss the Federal Trade Commission,s lawsuit, ... the result of a decision by a 5 to 3 ... and adopted the traditional "rule of reason" as the standard.  ...
Breaking Medicine Technology:New drug proving effective in attacking advanced prostate cancer 2Mid-Atlantic Biotech Leaders Featured On BioSpace Map 2U.S. Supreme Court Reverses U.S. Court of Appeals Decision in FTC v. Actavis 2U.S. Supreme Court Reverses U.S. Court of Appeals Decision in FTC v. Actavis 3
Cached News: